Addex Therapeutics Ltd. (ADXN) stock
ADXNNasdaqPharmaceutical PreparationsFiscal year ends December 31
$3.06−0.44 (-12.57%)
Close on Nov 18, 2026Market cap $62.83KP/E –Yield –
Addex Therapeutics cash
Cash and short-term investments held at the end of each period.
Addex Therapeutics's cash was CHF 767.33K at Jun 30, 2026. For fiscal 2025 it was CHF 1.64M, down 51.0% from the year before. The highest annual figure on record is CHF 31.54M in fiscal 2018.
Annual cash
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | CHF 1.64M | -51.0% |
| FY2024 | Dec 31, 2024 | CHF 3.34M | -13.5% |
| FY2023 | Dec 31, 2023 | CHF 3.87M | -44.4% |
| FY2022 | Dec 31, 2022 | CHF 6.96M | -66.0% |
| FY2021 | Dec 31, 2021 | CHF 20.48M | +9.6% |
| FY2020 | Dec 31, 2020 | CHF 18.70M | -40.7% |
| FY2019 | Dec 31, 2019 | CHF 31.54M | 0.0% |
| FY2018 | Dec 31, 2018 | CHF 31.54M | +1122.7% |
| FY2017 | Dec 31, 2017 | CHF 2.58M | +82.9% |
| FY2016 | Dec 31, 2016 | CHF 1.41M | – |
Quarterly cash
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | CHF 767.33K | -79.7% |
| Q4 FY2025 | Dec 31, 2025 | CHF 1.64M | -57.6% |
| Q2 FY2025 | Jun 30, 2025 | CHF 2.30M | -67.9% |
| Q4 FY2024 | Dec 31, 2024 | CHF 3.34M | -52.0% |
| Q2 FY2024 | Jun 30, 2024 | CHF 3.79M | -57.0% |
| Q4 FY2023 | Dec 31, 2023 | CHF 3.87M | -81.1% |
| Q2 FY2023 | Jun 30, 2023 | CHF 7.17M | -60.4% |
| Q4 FY2022 | Dec 31, 2022 | CHF 6.96M | -62.8% |
| Q2 FY2022 | Jun 30, 2022 | CHF 8.81M | -72.1% |
| Q4 FY2021 | Dec 31, 2021 | CHF 20.48M | -35.0% |
| Q2 FY2021 | Jun 30, 2021 | CHF 18.11M | +602.1% |
| Q4 FY2020 | Dec 31, 2020 | CHF 18.70M | +1225.8% |
| Q4 FY2019 | Dec 31, 2019 | CHF 31.54M | – |
| Q4 FY2018 | Dec 31, 2018 | CHF 31.54M | – |
| Q4 FY2017 | Dec 31, 2017 | CHF 2.58M | – |
| Q4 FY2016 | Dec 31, 2016 | CHF 1.41M | – |
See a number that looks wrong?